Ceribell wins FDA clearance for AI epileptiform detection, artifact reduction in cloud portal

CBLL•2026-08-10

FDA clears two AI upgrades in Ceribell’s cloud Neurology Portal

Ceribell won FDA 510(k) clearance for two AI upgrades in its cloud Neurology Portal: epileptiform abnormality detection and artifact reduction.

The company said the update aims to speed critical-care EEG review, improve signal quality, and support faster bedside decisions, with no software installation required.

Ceribell wins FDA clearance for AI epileptiform detection, artifact reduction in cloud portal

FDA clears two AI upgrades in Ceribell’s cloud Neurology Portal

Related News

California Resources swings to 2Q FY26 profit of $514 million; revenue rises to $1.3 billion

Standard Lithium Q2 net loss narrows to USD 3.05 million; operating loss improves to USD 4.04 million

Griffon launches USD 800 million senior notes offering due 2034

Capricor Therapeutics updates financial calendar with Q2 results release, conference call and webcast scheduled

Beazer Homes USA, Inc. <BZH.N>: Oppenheimer cuts to perform from outperform